CBRS delivered its June 12 earnings print and dropped 5.5% the same day — yet the week still closed up 6.5%, leaving the post-results picture more complicated than a single-session move suggests.
The options market has undergone a clean directional shift since the print. Through late May, the put/call ratio ran above 0.90 — traders were heavily hedged heading into results. By June 12 it had fallen to 0.57, the lowest reading in the trailing history and well below the 52-week high of 0.92. That trajectory reflects a rotation out of protective puts and into calls after the event passed, suggesting the market digested the result as broadly acceptable rather than damaging. The 52-week low PCR sits at zero, so there is room for sentiment to get more bullish still — but the directional move away from defensiveness is clear.
Short positioning tells a different story. The fourfold jump in shares short that occurred on June 9 — ahead of the print — has not unwound. Shares short held at around 7.8 million as of June 11, roughly four times the 1.9 million level that persisted through most of May and early June. Availability has eased slightly from the 20.5% floor hit on June 9 — the tightest point in at least a year — to around 40%, which is still firmly in tight territory. For context, availability ran above 200% as recently as late May. Cost to borrow has come down sharply from a mid-May peak above 19% to just over 1.1%, but that compression reflects lenders accepting lower rates on a pool that has already been substantially drawn down, not a loosening of the borrow market. The ORTEX short score holds at 67, up from the mid-50s where it sat before the June 9 repositioning — a reading that places this stock in meaningfully elevated short-interest territory relative to the broader universe.
Wall Street consensus remains emphatically bullish. The ten initiations that landed on June 8-9 — from Morgan Stanley (Overweight, $250), Mizuho and UBS (both $300), Citigroup ($340), and half a dozen others — set a consensus target of $293 against a current price of $214, implying roughly 37% upside from here. Every firm initiated at Buy, Outperform, or Overweight; not a single neutral or cautious rating entered the mix. The bull case rests on Cerebras's OpenAI and AWS partnerships, its custom silicon positioning in large-model inference, and an expected revenue and profit inflection through 2026-27. Bears counter with the heavy upfront capital demands of the dedicated-capacity model, customer concentration, and the risk that larger chipmakers encroach on the niche. With no prior analyst ratings to compare against, the entire sell-side view is effectively brand new — which makes the uniformity of direction notable, but also means there is no disconfirming voice yet.
The ownership structure reinforces the growth-investor bent. FMR (Fidelity) holds 11.6% of shares, making it the largest institutional position. Foundation Capital, Benchmark, Eclipse Operations, and Alpha Wave Global each hold between 5% and 7% — a venture and growth-capital roster that suggests the float is relatively concentrated in hands with long time horizons. Insiders sold in May at $185 — the CEO, CTO, COO, and chief accounting officer all transacted on May 13 — generating a net selling figure of roughly $132 million over the 90-day window. Those sales occurred at prices roughly 13% below the current level, which means insiders exited ahead of a move higher, though the sales pattern itself is consistent with post-IPO lock-up behaviour rather than fundamental conviction selling.
The setup heading into next week is defined by two forces pulling in opposite directions: a unanimous analyst chorus pointing to $293 or higher, and a short base that built aggressively ahead of earnings and has not yet moved to cover. Availability at 40% is tighter than normal but no longer at its floor — the question is whether the bulls' post-earnings call rotation translates into sustained price recovery that forces short covering, or whether the bears who built positions into the print find fresh reason to add.
See the live data behind this article on ORTEX.
Open CBRS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
